Treatment interruptions and non-adherence with imatinib and associated healthcare costs: A retrospective analysis among managed care patients with chronic myelogenous leukaemia

Theodore Darkow, Henry J. Henk, Simu K. Thomas, Weiwei Feng, Jean Francois Baladi, George A. Goldberg, Alan Hatfield, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

220 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment interruptions and non-adherence with imatinib and associated healthcare costs: A retrospective analysis among managed care patients with chronic myelogenous leukaemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences